| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 641,929 | 509,871 | 553,591 | 508,669 | | Cost of Revenue | 357,012 | 293,631 | 313,200 | 289,712 | | | Gross Profit | 284,917 | 216,240 | 240,391 | 218,957 | | | Operating Expenses | | Research Development | 38,093 | 35,325 | 36,979 | 36,978 | | Selling General and Administrative | 96,141 | 78,427 | 81,183 | 83,233 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 150,683 | 102,488 | 122,229 | 98,746 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 768 | 687 | 877 | 2,262 | | Earnings Before Interest And Taxes | 151,451 | 103,175 | 123,106 | 101,008 | | Interest Expense | 1,030 | 920 | 1,194 | 953 | | Income Before Tax | 150,421 | 102,255 | 121,912 | 100,055 | | Income Tax Expense | 53,233 | 16,904 | 42,554 | 30,476 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 97,188 | 85,351 | 79,358 | 69,579 | | | Non-recurring Events | | Discontinued Operations | (127) |
-
| (11,545) | (782) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 97,061 | 85,351 | 67,813 | 68,797 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $97,061 | $85,351 | $67,813 | $68,797 |
|
0.01% Nasdaq 0.00%
Income Statement
